Skip to Main Content

Paper Details

Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2/IRAK1/NFκB Signaling Pathway.
PLoS Pathog
75
2015
CMV, HCMV, HCMV envelope proteins, HCMV miR, HCMV miR-UL112-3p, HCMV miRNA, Human Cytomegalovirus, Human Cytomegalovirus miR-UL112-3p, IL-1, IL-6, IL-8, IRAK1, Luciferase reporter, NFB, NFB reporter cell line, TLR, TLR-2, TLR2, TLR2 protein, Toll-Like Receptor, UL112, endogenous, fibroblasts, gB, gH, humans, luciferase, miR, miR-, miR-UL112, miR-UL112-, miR-UL112-3p, miRNAs, mice, microRNAs, monocytic THP1 cells, viral miRNA
3' Untranslated Regions, Cells, Cultured, Cytomegalovirus, Fibroblasts, Genes, Reporter, HEK293 Cells, Humans, Immunity, Innate, Interleukin-1 Receptor-Associated Kinases, Ligands, MicroRNAs, Monocytes, Mutation, NF-kappa B, RNA Interference, RNA, Small Interfering, RNA, Viral, Recombinant Proteins, Signal Transduction, Toll-Like Receptor 2
Author NameAffiliation
Igor LandaisVaccine and Gene Therapy Institute, Oregon Health and Science University
Chantel PeltonVaccine and Gene Therapy Institute, Oregon Health and Science University
Daniel N StreblowVaccine and Gene Therapy Institute, Oregon Health and Science University
Victor R DeFilippisVaccine and Gene Therapy Institute, Oregon Health and Science University
Shannon K McWeeneyOregon Health and Science University
Jay A NelsonVaccine and Gene Therapy Institute, Oregon Health and Science University
  • 1 - 6

Datasets

Release 1.2